Latest Pharma Insights
Mismatch Between Growing Vaccine Pipeline and CDC’s ACIP Capacity
The Centers for Disease Control and Prevention’s ACIP is not able to take on all vaccine-like preventative medicines and still...
Pink Sheet - April 26, 2024
The Centers for Disease Control and Prevention’s ACIP is not able to take on all vaccine-like preventative medicines and still...
Pink Sheet - April 26, 2024
Finance Watch: Investors Support Strategic Shifts At Cullinan, Cidara
Public Company Edition: Cullinan and Cidara shifted their strategic directions and found investors to bring along for the ride. Also...
Scrip - April 26, 2024
Public Company Edition: Cullinan and Cidara shifted their strategic directions and found investors to bring along for the ride. Also...
Scrip - April 26, 2024
Humira Market Erosion Is Continuing As Expected, AbbVie Says
With adalimumab biosimilar market share increasing in the US, AbbVie says revenue erosion is on its expected pace, driven mainly...
Scrip - April 26, 2024
With adalimumab biosimilar market share increasing in the US, AbbVie says revenue erosion is on its expected pace, driven mainly...
Scrip - April 26, 2024
News We're Watching: LDT Final Rule Near Publication, Zimmer ROSA Used In Shoulder Surgery, $60M For Menopause Clinic
This week, the US FDA's proposed final rule on lab-developed tests cleared another hurdle on the path to release; Zimmer...
Medtech Insight - April 26, 2024
This week, the US FDA's proposed final rule on lab-developed tests cleared another hurdle on the path to release; Zimmer...
Medtech Insight - April 26, 2024
Keeping Track: Two Breakthrough Oncologics, Another Antibiotic Clear US FDA Along With Pfizer’s Hemophilia B Gene Therapy
The US FDA approved Day One’s pediatric brain cancer drug Ojemda, ImmunityBio’s bladder cancer immunotherapy Anktiva, an uncomplicated UTI claim...
Pink Sheet - April 26, 2024
The US FDA approved Day One’s pediatric brain cancer drug Ojemda, ImmunityBio’s bladder cancer immunotherapy Anktiva, an uncomplicated UTI claim...
Pink Sheet - April 26, 2024
Pfizer Matches Beqvez Price To Hemgenix In Hemophilia B, Plans Warranty Program
The drug maker said the program would allow for continued reimbursement when patients change insurance plans. A Sangamo-partnered gene therapy...
Scrip - April 26, 2024
The drug maker said the program would allow for continued reimbursement when patients change insurance plans. A Sangamo-partnered gene therapy...
Scrip - April 26, 2024
Priority Review Vouchers: Tropical Disease Candidates Wait Years For FDA Action On Qualifying List
There are pending requests to add 13 candidates to the tropical diseases that qualify for a priority review voucher, according...
Pink Sheet - April 26, 2024
There are pending requests to add 13 candidates to the tropical diseases that qualify for a priority review voucher, according...
Pink Sheet - April 26, 2024
Pink Sheet Podcast: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics
Pink Sheet reporter and editors discuss the impact of FDA biosimilar promotion guidance on the future of the interchangeability designation...
Pink Sheet - April 26, 2024
Pink Sheet reporter and editors discuss the impact of FDA biosimilar promotion guidance on the future of the interchangeability designation...
Pink Sheet - April 26, 2024
Beiersdorf Partners With Biopharma For Anti-Aging Skin Care Innovation; Beauty Business News
With NIVEA driving growth in its Consumer division, German firm Beiersdorf AG has signed a multi-year deal with Rubedo Life...
HBW Insight - April 26, 2024
With NIVEA driving growth in its Consumer division, German firm Beiersdorf AG has signed a multi-year deal with Rubedo Life...
HBW Insight - April 26, 2024
Analysis: Novo And Lilly Make Their Money Work
Pharma groups must decide how best to invest their cash to generate the biggest returns, and while huge sums can...
Scrip - April 26, 2024
Pharma groups must decide how best to invest their cash to generate the biggest returns, and while huge sums can...
Scrip - April 26, 2024
Epitel Gets 510(k) Clearance On Remote EEG Technology
The REMI Remote EEG monitoring system and REMI Vigilenz AI could help patients with infrequent seizures get a quicker diagnosis.
Medtech Insight - April 26, 2024
The REMI Remote EEG monitoring system and REMI Vigilenz AI could help patients with infrequent seizures get a quicker diagnosis.
Medtech Insight - April 26, 2024
AstraZeneca’s Hot Streak Whets Investor Appetite For What’s Next
Outstanding Q1 growth in sales and profits have pleased the markets, and investors are now keen to hear more about...
Scrip - April 26, 2024
Outstanding Q1 growth in sales and profits have pleased the markets, and investors are now keen to hear more about...
Scrip - April 26, 2024
Idorsia’s Novel Hypertension Pill Among Eight New Drugs To Win EMA Nod
The European Medicines Agency believes Idorsia’s Jeraygo should be approved for use in the EU at two different doses rather...
Pink Sheet - April 26, 2024
The European Medicines Agency believes Idorsia’s Jeraygo should be approved for use in the EU at two different doses rather...
Pink Sheet - April 26, 2024
Sweden's InDex To Stay Afloat Thanks To Mystery Merger Partner
The writing was on the wall for InDex after cobitolimod flopped for ulcerative colitis but that should soon been scrubbed...
Scrip - April 26, 2024
The writing was on the wall for InDex after cobitolimod flopped for ulcerative colitis but that should soon been scrubbed...
Scrip - April 26, 2024
Clasado, Probi Funded Study Shows Synergistic Effect Of Synbiotic Combination
The combination of Clasado's Bimuno GOS prebiotic and Probi's Defendum probiotic has been shown to significantly increase lactate levels and...
HBW Insight - April 26, 2024
The combination of Clasado's Bimuno GOS prebiotic and Probi's Defendum probiotic has been shown to significantly increase lactate levels and...
HBW Insight - April 26, 2024
Qunol Acquisition Gets Sanofi CHC Off To Flying Start
Sanofi CHC sales up 9% in Q1 driven by addition of US healthy aging supplement brand Qunol. Separately, the Paris-based...
HBW Insight - April 26, 2024
Sanofi CHC sales up 9% in Q1 driven by addition of US healthy aging supplement brand Qunol. Separately, the Paris-based...
HBW Insight - April 26, 2024
AI Used In Drug R&D Likely Exempt From Tough EU AI Rules, Says EFPIA
The European Commission’s landmark AI Act will introduce strict new rules for AI systems, with the exception of products used...
Pink Sheet - April 26, 2024
The European Commission’s landmark AI Act will introduce strict new rules for AI systems, with the exception of products used...
Pink Sheet - April 26, 2024
EU Parliament OKs New Rules On Use Of Patient Data In Research
The European Health Data Space is expected to give researchers, industry and public bodies access to large amounts of high-quality...
Pink Sheet - April 26, 2024
The European Health Data Space is expected to give researchers, industry and public bodies access to large amounts of high-quality...
Pink Sheet - April 26, 2024
Biocon And Biomm Team Up In Brazil On Ozempic Rival – With Potential Near-Term Launch
India’s Biocon Limited has struck an exclusive deal for a generic version of semaglutide in Brazil with local player Biomm...
Generics Bulletin - April 26, 2024
India’s Biocon Limited has struck an exclusive deal for a generic version of semaglutide in Brazil with local player Biomm...
Generics Bulletin - April 26, 2024
Amneal Launches Ready-To-Use Pemetrexed And OTC Naloxone
Amneal launched two highly anticipated products, a ready-to-use pemetrexed injectable Pemrydi and over-the-counter naloxone spray, strengthening the firm’s focus on...
Generics Bulletin - April 26, 2024
Amneal launched two highly anticipated products, a ready-to-use pemetrexed injectable Pemrydi and over-the-counter naloxone spray, strengthening the firm’s focus on...
Generics Bulletin - April 26, 2024
…And Amgen Makes Three: Another Ustekinumab Biosimilar Gets Go-Ahead In EU
At the latest meeting of the EMA’s CHMP committee, the agency recommended that Amgen be granted a third European marketing...
Generics Bulletin - April 26, 2024
At the latest meeting of the EMA’s CHMP committee, the agency recommended that Amgen be granted a third European marketing...
Generics Bulletin - April 26, 2024
No Takers For Biogen’s Biosimilars Business?
It’s been a year since Biogen made it clear that it was ready to put its biosimilars business on the...
Generics Bulletin - April 26, 2024
It’s been a year since Biogen made it clear that it was ready to put its biosimilars business on the...
Generics Bulletin - April 26, 2024
Valuable Health Data Sources For Medtech Industry Come A Step Closer In The EU
The only step that remains now before the European Health Data Space Regulation is approved is sign off by the...
Medtech Insight - April 26, 2024
The only step that remains now before the European Health Data Space Regulation is approved is sign off by the...
Medtech Insight - April 26, 2024
Danes Advise Pharma Firms To Test Their Anti-Tamper Devices
About 10% of marketed medicines chosen at random in Denmark had “non-functioning” anti-tamper devices, leaving them open to possible interference.
Pink Sheet - April 26, 2024
About 10% of marketed medicines chosen at random in Denmark had “non-functioning” anti-tamper devices, leaving them open to possible interference.
Pink Sheet - April 26, 2024
Biogen Chases Fresenius After Revealing EU Tocilizumab Nod
Ahead of the EMA’s CHMP publishing its April meeting highlights, Biogen has revealed a positive opinion for its Tofidence biosimilar...
Generics Bulletin - April 26, 2024
Ahead of the EMA’s CHMP publishing its April meeting highlights, Biogen has revealed a positive opinion for its Tofidence biosimilar...
Generics Bulletin - April 26, 2024
Joint Clinical Assessments: EU Guidance On Evidence May Be Flexible For ATMPs And Single Arm Trials
Real-world evidence and patient involvement can help developers shore up evidence from single arm trials for EU-wide joint clinical assessments.
Pink Sheet - April 26, 2024
Real-world evidence and patient involvement can help developers shore up evidence from single arm trials for EU-wide joint clinical assessments.
Pink Sheet - April 26, 2024
China Biotech Podcast: AACR, BIOSECURE European Perspectives
Guest Andrew McConaghie from Scrip's UK team joins Brian Yang and Dexter Yan to discuss AACR highlights from Chinese biotechs...
Scrip - April 26, 2024
Guest Andrew McConaghie from Scrip's UK team joins Brian Yang and Dexter Yan to discuss AACR highlights from Chinese biotechs...
Scrip - April 26, 2024
Finance Watch: Investors Support Strategic Shifts At Cullinan, Cidara
Public Company Edition: Cullinan and Cidara shifted their strategic directions and found investors to bring along for the ride. Also...
Scrip - April 26, 2024
Public Company Edition: Cullinan and Cidara shifted their strategic directions and found investors to bring along for the ride. Also...
Scrip - April 26, 2024
Humira Market Erosion Is Continuing As Expected, AbbVie Says
With adalimumab biosimilar market share increasing in the US, AbbVie says revenue erosion is on its expected pace, driven mainly...
Scrip - April 26, 2024
With adalimumab biosimilar market share increasing in the US, AbbVie says revenue erosion is on its expected pace, driven mainly...
Scrip - April 26, 2024
Pfizer Matches Beqvez Price To Hemgenix In Hemophilia B, Plans Warranty Program
The drug maker said the program would allow for continued reimbursement when patients change insurance plans. A Sangamo-partnered gene therapy...
Scrip - April 26, 2024
The drug maker said the program would allow for continued reimbursement when patients change insurance plans. A Sangamo-partnered gene therapy...
Scrip - April 26, 2024
Analysis: Novo And Lilly Make Their Money Work
Pharma groups must decide how best to invest their cash to generate the biggest returns, and while huge sums can...
Scrip - April 26, 2024
Pharma groups must decide how best to invest their cash to generate the biggest returns, and while huge sums can...
Scrip - April 26, 2024
AstraZeneca’s Hot Streak Whets Investor Appetite For What’s Next
Outstanding Q1 growth in sales and profits have pleased the markets, and investors are now keen to hear more about...
Scrip - April 26, 2024
Outstanding Q1 growth in sales and profits have pleased the markets, and investors are now keen to hear more about...
Scrip - April 26, 2024
Sweden's InDex To Stay Afloat Thanks To Mystery Merger Partner
The writing was on the wall for InDex after cobitolimod flopped for ulcerative colitis but that should soon been scrubbed...
Scrip - April 26, 2024
The writing was on the wall for InDex after cobitolimod flopped for ulcerative colitis but that should soon been scrubbed...
Scrip - April 26, 2024
China Biotech Podcast: AACR, BIOSECURE European Perspectives
Guest Andrew McConaghie from Scrip's UK team joins Brian Yang and Dexter Yan to discuss AACR highlights from Chinese biotechs...
Scrip - April 26, 2024
Guest Andrew McConaghie from Scrip's UK team joins Brian Yang and Dexter Yan to discuss AACR highlights from Chinese biotechs...
Scrip - April 26, 2024
Mismatch Between Growing Vaccine Pipeline and CDC’s ACIP Capacity
The Centers for Disease Control and Prevention’s ACIP is not able to take on all vaccine-like preventative medicines and still...
Pink Sheet - April 26, 2024
The Centers for Disease Control and Prevention’s ACIP is not able to take on all vaccine-like preventative medicines and still...
Pink Sheet - April 26, 2024
Keeping Track: Two Breakthrough Oncologics, Another Antibiotic Clear US FDA Along With Pfizer’s Hemophilia B Gene Therapy
The US FDA approved Day One’s pediatric brain cancer drug Ojemda, ImmunityBio’s bladder cancer immunotherapy Anktiva, an uncomplicated UTI claim...
Pink Sheet - April 26, 2024
The US FDA approved Day One’s pediatric brain cancer drug Ojemda, ImmunityBio’s bladder cancer immunotherapy Anktiva, an uncomplicated UTI claim...
Pink Sheet - April 26, 2024
Priority Review Vouchers: Tropical Disease Candidates Wait Years For FDA Action On Qualifying List
There are pending requests to add 13 candidates to the tropical diseases that qualify for a priority review voucher, according...
Pink Sheet - April 26, 2024
There are pending requests to add 13 candidates to the tropical diseases that qualify for a priority review voucher, according...
Pink Sheet - April 26, 2024
Pink Sheet Podcast: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics
Pink Sheet reporter and editors discuss the impact of FDA biosimilar promotion guidance on the future of the interchangeability designation...
Pink Sheet - April 26, 2024
Pink Sheet reporter and editors discuss the impact of FDA biosimilar promotion guidance on the future of the interchangeability designation...
Pink Sheet - April 26, 2024
Idorsia’s Novel Hypertension Pill Among Eight New Drugs To Win EMA Nod
The European Medicines Agency believes Idorsia’s Jeraygo should be approved for use in the EU at two different doses rather...
Pink Sheet - April 26, 2024
The European Medicines Agency believes Idorsia’s Jeraygo should be approved for use in the EU at two different doses rather...
Pink Sheet - April 26, 2024
AI Used In Drug R&D Likely Exempt From Tough EU AI Rules, Says EFPIA
The European Commission’s landmark AI Act will introduce strict new rules for AI systems, with the exception of products used...
Pink Sheet - April 26, 2024
The European Commission’s landmark AI Act will introduce strict new rules for AI systems, with the exception of products used...
Pink Sheet - April 26, 2024
EU Parliament OKs New Rules On Use Of Patient Data In Research
The European Health Data Space is expected to give researchers, industry and public bodies access to large amounts of high-quality...
Pink Sheet - April 26, 2024
The European Health Data Space is expected to give researchers, industry and public bodies access to large amounts of high-quality...
Pink Sheet - April 26, 2024
Danes Advise Pharma Firms To Test Their Anti-Tamper Devices
About 10% of marketed medicines chosen at random in Denmark had “non-functioning” anti-tamper devices, leaving them open to possible interference.
Pink Sheet - April 26, 2024
About 10% of marketed medicines chosen at random in Denmark had “non-functioning” anti-tamper devices, leaving them open to possible interference.
Pink Sheet - April 26, 2024
Joint Clinical Assessments: EU Guidance On Evidence May Be Flexible For ATMPs And Single Arm Trials
Real-world evidence and patient involvement can help developers shore up evidence from single arm trials for EU-wide joint clinical assessments.
Pink Sheet - April 26, 2024
Real-world evidence and patient involvement can help developers shore up evidence from single arm trials for EU-wide joint clinical assessments.
Pink Sheet - April 26, 2024
News We're Watching: LDT Final Rule Near Publication, Zimmer ROSA Used In Shoulder Surgery, $60M For Menopause Clinic
This week, the US FDA's proposed final rule on lab-developed tests cleared another hurdle on the path to release; Zimmer...
Medtech Insight - April 26, 2024
This week, the US FDA's proposed final rule on lab-developed tests cleared another hurdle on the path to release; Zimmer...
Medtech Insight - April 26, 2024
Epitel Gets 510(k) Clearance On Remote EEG Technology
The REMI Remote EEG monitoring system and REMI Vigilenz AI could help patients with infrequent seizures get a quicker diagnosis.
Medtech Insight - April 26, 2024
The REMI Remote EEG monitoring system and REMI Vigilenz AI could help patients with infrequent seizures get a quicker diagnosis.
Medtech Insight - April 26, 2024
Valuable Health Data Sources For Medtech Industry Come A Step Closer In The EU
The only step that remains now before the European Health Data Space Regulation is approved is sign off by the...
Medtech Insight - April 26, 2024
The only step that remains now before the European Health Data Space Regulation is approved is sign off by the...
Medtech Insight - April 26, 2024
Beiersdorf Partners With Biopharma For Anti-Aging Skin Care Innovation; Beauty Business News
With NIVEA driving growth in its Consumer division, German firm Beiersdorf AG has signed a multi-year deal with Rubedo Life...
HBW Insight - April 26, 2024
With NIVEA driving growth in its Consumer division, German firm Beiersdorf AG has signed a multi-year deal with Rubedo Life...
HBW Insight - April 26, 2024
Clasado, Probi Funded Study Shows Synergistic Effect Of Synbiotic Combination
The combination of Clasado's Bimuno GOS prebiotic and Probi's Defendum probiotic has been shown to significantly increase lactate levels and...
HBW Insight - April 26, 2024
The combination of Clasado's Bimuno GOS prebiotic and Probi's Defendum probiotic has been shown to significantly increase lactate levels and...
HBW Insight - April 26, 2024
Qunol Acquisition Gets Sanofi CHC Off To Flying Start
Sanofi CHC sales up 9% in Q1 driven by addition of US healthy aging supplement brand Qunol. Separately, the Paris-based...
HBW Insight - April 26, 2024
Sanofi CHC sales up 9% in Q1 driven by addition of US healthy aging supplement brand Qunol. Separately, the Paris-based...
HBW Insight - April 26, 2024
Biocon And Biomm Team Up In Brazil On Ozempic Rival – With Potential Near-Term Launch
India’s Biocon Limited has struck an exclusive deal for a generic version of semaglutide in Brazil with local player Biomm...
Generics Bulletin - April 26, 2024
India’s Biocon Limited has struck an exclusive deal for a generic version of semaglutide in Brazil with local player Biomm...
Generics Bulletin - April 26, 2024
Amneal Launches Ready-To-Use Pemetrexed And OTC Naloxone
Amneal launched two highly anticipated products, a ready-to-use pemetrexed injectable Pemrydi and over-the-counter naloxone spray, strengthening the firm’s focus on...
Generics Bulletin - April 26, 2024
Amneal launched two highly anticipated products, a ready-to-use pemetrexed injectable Pemrydi and over-the-counter naloxone spray, strengthening the firm’s focus on...
Generics Bulletin - April 26, 2024
…And Amgen Makes Three: Another Ustekinumab Biosimilar Gets Go-Ahead In EU
At the latest meeting of the EMA’s CHMP committee, the agency recommended that Amgen be granted a third European marketing...
Generics Bulletin - April 26, 2024
At the latest meeting of the EMA’s CHMP committee, the agency recommended that Amgen be granted a third European marketing...
Generics Bulletin - April 26, 2024
No Takers For Biogen’s Biosimilars Business?
It’s been a year since Biogen made it clear that it was ready to put its biosimilars business on the...
Generics Bulletin - April 26, 2024
It’s been a year since Biogen made it clear that it was ready to put its biosimilars business on the...
Generics Bulletin - April 26, 2024
Biogen Chases Fresenius After Revealing EU Tocilizumab Nod
Ahead of the EMA’s CHMP publishing its April meeting highlights, Biogen has revealed a positive opinion for its Tofidence biosimilar...
Generics Bulletin - April 26, 2024
Ahead of the EMA’s CHMP publishing its April meeting highlights, Biogen has revealed a positive opinion for its Tofidence biosimilar...
Generics Bulletin - April 26, 2024
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One...
In Vivo - April 24, 2024
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One...
In Vivo - April 24, 2024
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in...
In Vivo - April 24, 2024
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in...
In Vivo - April 24, 2024
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic...
In Vivo - April 24, 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic...
In Vivo - April 24, 2024
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care...
In Vivo - April 24, 2024
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care...
In Vivo - April 24, 2024